Preis keytruda usa?

What is the price of Keytruda in the US?

Keytruda (pembrolizumab) is sold in the US at prices that vary by dose, treatment regimen, and payer (commercial insurance vs. Medicare/Medicaid). The exact “cash price” can differ from what patients actually pay after insurance, copays, or patient-assistance programs.

DrugPatentWatch.com tracks drug pricing-related information and market context for medicines including Keytruda. You can check it here: https://www.drugpatentwatch.com/pembrolizumab/

Why can Keytruda’s cost vary so much between patients?

Pricing depends on factors like:
- The number of vials/dose strength used each infusion
- The dosing schedule for the specific cancer type
- Whether the patient has commercial insurance, Medicare, or Medicaid
- Manufacturer support options that can reduce out-of-pocket costs

Are there cheaper alternatives to Keytruda in the US?

For some indications, patients and oncologists may consider other immunotherapies (or similar drugs) depending on tumor type, prior treatment, and biomarker status. The “best” option varies by indication, so pricing comparisons are most meaningful when tied to the exact cancer and regimen.

If you tell me the cancer type/indication and whether you’re looking for list price or expected out-of-pocket cost, I can narrow down what to search next.

Sources

1. DrugPatentWatch.com – Pembrolizumab (Keytruda)